文献速递生殖医学

多囊卵巢综合征患者血浆非酯化脂肪酸(NEFA)动力学改变及其与胰岛素抵抗的关系

Alterations in plasma non-esterified fatty acid (NEFA) kinetics and relationship with insulin resistance in polycystic ovary syndrome.
PubMed 文献 · Hum Reprod · 2019-01-01

该前瞻性研究比较了29例多囊卵巢综合征(PCOS)患者与29例BMI匹配的健康对照者的胰岛素敏感性和NEFA动力学,发现PCOS患者尤其是肥胖者存在NEFA动力学异常,表现为基础血浆NEFA水平降低和葡萄糖介导的脂肪分解抑制增强,且这些改变与胰岛素抵抗独立相关。

要点

  • PCOS患者基础血浆NEFA水平(直接测定和模型推导的NEFA0)低于健康对照。
  • PCOS患者葡萄糖介导的脂肪分解抑制增强,表现为亲和常数Φ降低。
  • NEFA动力学差异在肥胖PCOS患者中加剧且几乎仅见于该亚组。

核心结论

  • PCOS患者尤其是肥胖者存在NEFA动力学失调,且与胰岛素抵抗独立相关,而不依赖于空腹血浆NEFA水平。

研究设计与样本

  • 前瞻性研究,纳入29例PCOS患者和29例BMI匹配的健康对照女性,在三级机构进行。

主要发现

  • PCOS患者基础血浆NEFA水平(直接测定和模型推导的NEFA0)低于健康对照。
  • PCOS患者葡萄糖介导的脂肪分解抑制增强,表现为亲和常数Φ降低。
  • 脂肪组织最大脂肪分解速率(SFFA)和NEFA离开血浆池的速率(KFFA)在两组间无差异。
  • NEFA动力学差异在肥胖PCOS患者中加剧,且几乎仅见于肥胖PCOS亚组。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 本研究未研究NEFA亚型。
  • 研究为横断面设计,且基于1990年美国国立卫生研究院(NIH)标准定义(即A型和B型表型)并在临床环境中识别的PCOS女性,因此将数据外推至其他PCOS表型应谨慎。
  • 数据为探索性,需要更大样本量验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Are non-esterified fatty acid (NEFA) kinetics altered in women with polycystic ovary syndrome (PCOS)? SUMMARY ANSWER: Women with PCOS, particularly obese subjects, have dysregulated plasma NEFA kinetics in response to changes in plasma insulin and glucose levels, which are associated with insulin resistance (IR) independently of the fasting plasma NEFA levels. WHAT IS KNOWN ALREADY: Elevated plasma NEFA levels are associated with IR in many disorders, although the homeostasis of NEFA kinetics and its relationship to IR in women with PCOS is unknown. STUDY DESIGN, SIZE, DURATION: We prospectively compared insulin sensitivity and NEFA kinetics in 29 PCOS and 29 healthy controls women matched for BMI. PARTICIPANTS/MATERIALS, SETTING, METHODS: This study was conducted in a tertiary institution. Plasma NEFA, glucose and insulin levels were assessed during a modified frequently sampled intravenous glucose tolerance test (mFSIVGTT). Minimal models were used to assess insulin sensitivity (Si) and NEFA kinetics (i.e. model-derived initial plasma NEFA level [NEFA0], phi constant [Φ], reflecting glucose-mediated inhibition of lipolysis and measures of maximum rate of lipolysis [SFFA] and NEFA uptake from plasma [KFFA]). MAIN RESULTS AND THE ROLE OF CHANCE: The study provides new evidence that women with PCOS have defective NEFA kinetics characterized by: (i) lower basal plasma NEFA levels, measured directly and modeled (NEFA0), and (ii) a greater glucose-mediated inhibition of lipolysis in the remote or interstitial space (reflected by a lower affinity constant [Φ]). There were no differences, however, in the maximal rates of adipose tissue lipolysis (SFFA) and the rate at which NEFA leaves the plasma pool (KFFA). The differences observed in NEFA kinetics were exacerbated, and almost exclusively observed, in the obese PCOS subjects. LIMITATIONS, REASONS FOR CAUTION: Our study did not study NEFA subtypes. It was also cross-sectional and based on women affected by PCOS as defined by the 1990 National Institutes of Health (NIH) criteria (i.e. Phenotypes A and B) and identified in the clinical setting. Consequently, extrapolation of the present data to other phenotypes of PCOS should be made with caution. Furthermore, our data is exploratory and therefore requires validation with a larger sample size. WIDER IMPLICATIONS OF THE FINDINGS: Dysfunction in NEFA kinetics may be a marker of metabolic dysfunction in nondiabetic obese women with PCOS and may be more important than simply assessing circulating NEFA levels at a single point in time for understanding the mechanism(s) underlying the IR of PCOS. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by NIH grants R01-DK073632 and R01-HD29364 to R.A.; a Career Development Award from MD Medical Group, Moscow, RF, to D.L. and Augusta University funds to Y.-H.C. RA serves as consultant to Ansh Labs, Medtronics, Spruce Biosciences and Latitude Capital. U.E., Z.A., D.L., R.M., Y.-H.C., R.C.B. and Y.D.I.C. have no competing interests to declare. TRIAL REGISTRATION NUMBER: Not applicable.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Ezeh U, Arzumanyan Z, Lizneva D, et al. Alterations in plasma non-esterified fatty acid (NEFA) kinetics and relationship with insulin resistance in polycystic ovary syndrome. Hum Reprod. 2019. PMID: 30576500. doi:10.1093/humrep/dey356

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。